IMROZ- IsaRVd vs RVd in Newly Diagnosed Transplant Ineligible MM | Thierry Facon, MD | EHA 2024
Vložit
- čas přidán 20. 06. 2024
- Thierry Facon, MD, discusses the results of a study analyzing Isa-VRd for patients with newly diagnosed multiple myeloma who may not be eligible for transplant.
library.ehaweb.org/eha/2024/e...
The HealthTree Foundation for Multiple Myeloma brings information from the experts to the patients! Learn more at www.healthtree.org/myeloma/co...
Donate to the HealthTree Foundation for Multiple Myeloma or learn more about additional myeloma support we offer here: give.healthtree.org/campaign/...
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at www.healthtree.org/
Follow HealthTree:
healthtreeformm
healthtreeformultiplemyeloma
instragram.com/healthtreeformultiplemyeloma - Věda a technologie